您好,欢迎访问山东省农业科学院文献资源数据库平台

Sifting through the core-genome to identify putative cross-protective antigens against Riemerella anatipestifer

文献类型: 外文期刊

作者: Zheng, Xiangkuan 1 ; Xu, Sixiang 1 ; Wang, Zhuohao 1 ; Tao, Xingyu 1 ; Liu, Yuqing 5 ; Dai, Lei 6 ; Li, Yubao 7 ; Zhang, Wei 1 ;

作者机构: 1.Sanya Inst Nanjing Agr Univ, Sanya 572024, Peoples R China

2.Minist Agr, Key Lab Anim Bacteriol, Nanjing 210095, Peoples R China

3.OIE Reference Lab Swine Streptococcosis, Nanjing 210095, Peoples R China

4.Nanjing Agr Univ, Coll Vet Med, Nanjing 210095, Peoples R China

5.Shandong Acad Agr Sci, Inst Anim Sci & Vet Med, Jinan 250100, Shandong, Peoples R China

6.Hainan Anim Dis Prevent & Control Ctr, 16 Xingdan Rd, Haikou 571100, Peoples R China

7.Liaocheng Univ, Agr Sci & Engn Sch, Liaocheng, Peoples R China

关键词: Riemerella anatipestifer; Core-genome; Pan-genome; Reverse vaccinology; Cross-protective antigens; Subunit vaccine

期刊名称:APPLIED MICROBIOLOGY AND BIOTECHNOLOGY ( 影响因子:5.0; 五年影响因子:5.2 )

ISSN: 0175-7598

年卷期: 2023 年 107 卷 9 期

页码:

收录情况: SCI

摘要: Infectious serositis of ducks, caused by Riemerella anatipestifer, is one of the main infectious diseases that harm commercial ducks. Whole-strain-based vaccines with no or few cross-protection were observed between different serotypes of R. anatipestifer, and so far, control of infection is hampered by a lack of effective vaccines, especially subunit vaccines with cross-protection. Since the concept of reverse vaccinology was introduced, it has been widely used to screen for protective antigens in important pathogens. In this study, pan-genome binding reverse vaccinology, an emerging approach to vaccine candidate screening, was used to screen for cross-protective antigens against R. anatipestifer. Thirty proteins were identified from the core-genome as potential cross-protective antigens. Three of these proteins were recombinantly expressed, and their immunoreactivity with five antisera (anti-serotypes 1, 2, 6, 10, and 11) was demonstrated by Western blotting. Our study established a method for high-throughput screening of cross-protective antigens against R. anatipestifer in silico, which will lay the foundation for the development of a cross-protective subunit vaccine controlling R. anatipestifer infection.

  • 相关文献
作者其他论文 更多>>